Suminlao, Freelt .
HRN: 25-20-53 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2024
CEFUROXIME 1.5GM (VIAL)
06/11/2024
06/12/2024
IV
1.5
Q8
CS
Waiting Final Action
06/11/2024
CEFUROXIME 500MG (TAB)
06/12/2024
06/18/2024
PO
500mg
BID
Cs
Waiting Final Action
06/11/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/11/2024
06/12/2024
IV
500ng
Q8
Cs
Waiting Final Action
06/11/2024
METRONIDAZOLE 500MG (TAB)
06/12/2024
06/17/2024
PO
500mg
TID
Cs
Waiting Final Action